Neurogene Inc. (LS:A3EX79) IPO
IPO
Went public as AQUINOX PHARMACEUTICALS, INC. Priced at US$11.00 a share on Mar 6, 2014.
- Price
- US$11.00 a share
- Shares offered
- 4,200,000 shares of common stock
- Offering size
- US$46.2 million
- Underwriters' option
- Up to 630,000 more shares
- Underwriters
- Jefferies, Cowen and Company, Canaccord Genuity · In the order on the cover
- Shares delivered
- On or about Mar 12, 2014
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 18, 2013 |
| Filed publicly | Jan 28, 2014 |
| Amended once | Feb 28, 2014 |
| Shares registered with an exchange | Mar 3, 2014 |
| Declared effective by the SEC | Mar 6, 2014 |
| Final prospectus, with the price | Mar 7, 2014 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 7, 2014 |
| EFFECT · Notice that a registration is effective | Mar 6, 2014 |
| CERTNAS · Nasdaq's certificate of listing | Mar 4, 2014 |
| CORRESP · Letter to the SEC | Mar 4, 2014 |
| CORRESP · Letter to the SEC | Mar 4, 2014 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 3, 2014 |
| S-1/A · Registration statement, amended | Feb 28, 2014 |
| CORRESP · Letter to the SEC | Jan 28, 2014 |
| S-1 · Registration statement | Jan 28, 2014 |
| UPLOAD · Letter from the SEC | Jan 9, 2014 |
| DRSLTR · Letter to the SEC with a draft | Dec 24, 2013 |
| DRS/A · Draft registration statement, amended | Dec 24, 2013 |
| UPLOAD · Letter from the SEC | Dec 19, 2013 |
| DRS · Draft registration statement | Nov 18, 2013 |
From the cover of the final prospectus (424B4) filed Mar 7, 2014